Sarcomas Area

"We are a leading center for the treatment of sarcomas and pioneers in limb preservation programs. We also have a team of experts in retroperitoneal sarcomas and advanced technology such as proton therapy, which is key in the treatment of certain types of sarcoma."

DR. ALEJANDRO GALLEGO
COORDINATOR. SARCOMAS AREA

Merco Salud 2025 Medical Oncology recognition seal image. Clínica Universidad de Navarra

El Área de Sarcomas del Cancer Center Clínica Universidad de Navarra es uno de los centros de referencia internacional en el diagnóstico y tratamiento de esta enfermedad. Nuestro equipo multidisciplinar cuenta con una amplia experiencia en el abordaje de sarcomas, por lo que recibimos pacientes derivados desde toda España y de otros países.

Desde 1980, más de 2.000 pacientes con sarcoma han sido tratados en la Clínica. Somos además uno de los primeros centros del mundo en implantar programas de cirugía conservadora de la extremidad, que hoy nos permiten alcanzar tasas de conservación cercanas al 95%

Cada paciente recibe un diagnóstico y tratamiento personalizado, basado en el análisis anatomopatológico y genómico del tumor y en el uso de técnicas avanzados de radiodiagnóstico. Como en otros cánceres, el diagnóstico y tratamiento precoces son fundamentales para obtener los mejores resultados.

Entre nuestras principales innovaciones destaca la protonterapia, especialmente relevante en el tratamiento de algunos sarcomas complejos como los cordomas, ya que permite administrar radiación de alta precisión protegiendo al máximo los tejidos sanos cercanos.

Este enfoque integral, combinado con tecnología de última generación y un equipo altamente especializado, nos permite ofrecer resultados clínicos de referencia basados en una atención centrada en el paciente.

A PERSONALIZED MEDICINE

Second Opinion,
peace of mind

Request a second opinion from our professionals with great experience in the diagnosis and treatment of oncological diseases

In 3 days, without leaving home.

Advanced diagnosis and treatment for better care

It is extremely important that the diagnostic process and the initiation of treatment are as fast as possible.
 Delays can determine patient survival.

It is the most common childhood bone cancer, although its incidence is very low (1-2 cases per million inhabitants per year). That is the reason why it is important to carry out such treatments in experienced centres.

It usually affects children and adolescents, and the most frequent location is around the knee. Pain (mainly nocturnal) is the most frequent symptom, sometimes accompanied by an increase in volume of hard consistency.

Early diagnosis and treatment is of crucial importance to achieve the best survival rates and preservation of the limb.

Treatment consists of chemotherapy (at the Clinic we use intra-arterial chemotherapy to improve the response of the tumour) and surgery. The best results are achieved when the response to treatment is good and during surgery the tumour is completely removed. This requires the experience of a multidisciplinary team of radiologists, pathologists, oncologists, paediatricians, orthopaedic surgeons...

We have developed techniques such as epiphysiolysis prior to resection that manage to optimise the result, and which today have been spread worldwide via professionals who have trained at the Clinic.

It is the second most common bone sarcoma that also affects children and adolescents. Part of them are located in the axial skeleton (pelvis, spine, scapula, clavicle, ribs...) and the rest can appear in any bone.

Like osteosarcoma, nighttime pain in a child or adolescent is usually the initial symptom, with or without the appearance of a lump. The sooner treatment begins, the better the chance of cure.

Also in this tumour, the response to chemotherapy treatment is very important (although the drugs used are different from osteosarcoma) and good surgery which, in locations such as the pelvis or spine, is much more demanding than in the extremities. In some cases radiotherapy is also used.

In 80% of our cases, preoperative chemotherapy achieves rates of necrosis of the tumour close to 100%, which greatly facilitates its surgical resection.

An adult bone tumour can arise from a previous benign lesion (osteochondroma or chondroma) of childhood, or appear "exnovo". It can also produce night pain and the appearance of a hard lump of rapid growth.

It usually does not respond to chemotherapy or radiotherapy and therefore the main treatment is surgical. Some low-grade chondrosarcomas can be treated with very mild surgery, while high grade (II and III) require extensive surgery. Axial location chondrosarcomas require complex surgery.

It is a tumor of the epiphyses (the joint area) of the long bones. The most frequent locations are the knee and the wrist, in young adults (20-40 years old). It is a benign tumour, although locally aggressive.

The treatment was exclusively surgical until a decade ago, when a useful medication (Denosumab) was discovered in this tumour. Nowadays we use it as a previous treatment to facilitate surgery.

In most cases they are treated with curettage surgery (preserving the joint) and some adjuvant (liquid nitrogen, phenol, etc) to avoid recurrence.

This is a very heterogeneous group of tumours affecting the "non-bone" part of the locomotor system of the extremities and trunk. There are more than 60 different types, although the most common are those of the fatty lineage (liposarcomas), fibrous lineage (fifrosarcoma or fibrohistiocytoma), synovial sarcoma, neural lineage (schwanosarcomas), etc.

These are typical of adults and they are usually not very painful. The most frequent is the appearance of a lump of elastic consistency on a limb. The criteria for suspecting soft tissue sarcoma (when a lump appears) are:

  • Lump with a diameter greater than 4-5 cm (like a golf ball).
  • Painful.
  • Rapid growth (weeks).
  • Deep to the fascia.
  • Even without having any of the previous characteristics, a lump that is removed and reappears.

Diagnosis requires imaging techniques (MRI and PET are especially useful). A biopsy is necessary to confirm clinical suspicion.

The pathologist must also be an expert to be able to distinguish between some sarcomas and others, and to classify them according to their aggressiveness (high grade or low grade).

The most effective therapeutic weapon is complete resection of the tumour. Radiotherapy is indicated in most large and deep tumours of the fascia, whereas chemotherapy is occasionally applied to high grade sarcomas. The prognosis depends on the extension at the beginning, the size of the tumour and the histological grade.

In hands of expert, the cure rate is around 80%, with the limb being preserved in the vast majority of cases.

Experienced surgeons must operate them on. Radiotherapy is effective in large or deep fascia tumours, whereas chemotherapy has little efficacy, although it is used in high grade metastatic tumours or as prevention of possible metastasis.

They are 3 times more frequent than bone sarcomas and are often under-diagnosed and treated by inexperienced doctors from different specialities. This means that in countries where these cases are not treated in experienced centres, the cure rate is much lower.

Do you need to request a consultation with one of our specialists?

SPECIALISATION

The value of experience

At the Clínica Universidad de Navarra, we have treated nearly a thousand malignant primary bone tumours over the last twenty years. In osteosarcoma, to cite the most common, the survival rate is 74% at 10 years, with a limb preservation rate of over 90%.

Cirujanos en plena intervención quirúrgica de rodilla.


Precision surgery

In order to cure a malignant bone tumour it is necessary to remove the entire lesion, including the path of the previous biopsy. This is the reason why it is necessary for that biopsy to be performed by the surgeon who will carry out the definitive operation.

Enfermera y médico atienden a paciente con osteosarcoma.<br/>


Teamwork

It is necessary to unite everyone's efforts in order for each patient to be treated by a team that discusses and follows each case in particular in order to avoid any delays that may condition the effectiveness of the treatment.


Experience

The Clinic is one of the European centres with the greatest experience in musculoskeletal tumours and that offers one of the highest rates of preservation of the patient's limb in the world.

Imagen de la fachada de consultas de la sede en Pamplona de la Clínica Universidad de Navarra

Why choose the Clinic?

  • Integral evaluation of the patient.
  • Cutting-edge technology.
  • International reference professionals.
     

Our team of professionals

We keep on everyday researching in order to find solutions

Research against
musculoskeletal tumors

The Neuro-oncology, Sarcomas and Pediatric Tumors Research Area seeks to find innovative treatments that will make it possible to surpass the cure rate obtained to date.

As a result, there are numerous publications, many of them in collaboration with the most renowned researchers worldwide in this field.

Participation in these trials provides patients with new possibilities by allowing access to the latest therapeutic advances